| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bone metastases: Pathogenesis, treatment, and rationale for use of resorption inhibitors
|
Scher, Howard I.
|
|
1987
|
82 |
2S1 |
p. 6-28
23 p.
|
article
|
| 2 |
Effect of etidronate disodium on the interactions between malignancy and bone
|
Garattini, Silvio
|
|
1987
|
82 |
2S1 |
p. 29-33
5 p.
|
article
|
| 3 |
Effects of intravenous etidronate disodium on skeletal and calcium metabolism
|
Kanis, John A.
|
|
1987
|
82 |
2S1 |
p. 55-70
16 p.
|
article
|
| 4 |
Etidronate disodium in the management of malignancy-related hypercalcemia
|
Hasling, Claus
|
|
1987
|
82 |
2S1 |
p. 51-54
4 p.
|
article
|
| 5 |
Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy: Effects on biochemical parameters and bone histomorphometry
|
Meunier, Pierre J.
|
|
1987
|
82 |
2S1 |
p. 71-78
8 p.
|
article
|
| 6 |
Neoplastic hypercalcemia: Physiologic response to intravenous etidronate disodium
|
Jacobs, Thomas P.
|
|
1987
|
82 |
2S1 |
p. 42-50
9 p.
|
article
|
| 7 |
Publisher's note
|
|
|
1987
|
82 |
2S1 |
p. iii-
1 p.
|
article
|
| 8 |
Rationale for diphosphonate therapy in hypercalcemia of malignancy
|
Canfield, Robert E.
|
|
1987
|
82 |
2S1 |
p. 1-5
5 p.
|
article
|
| 9 |
Therapy of hypercalcemia of malignancy
|
Singer, Frederick R.
|
|
1987
|
82 |
2S1 |
p. 34-41
8 p.
|
article
|
Journal description